6-Fluoro-3-Hydroxypyrazine-2-Carbonitrile CAS 356783-31-8 Nadiifinta ≥98.0% (HPLC) Favipiravir Dhexdhexaad COVID-19

Sharaxaad Gaaban:

Magaca Kiimikada: 6-Fluoro-3-Hydroxypyrazine-2-Carbonitrile

6-Fluoro-3-oxo-3,4-Dihydropyrazine-2-Carbonitrile

CAS: 356783-31-8

Muuqashada: Jaalle cirro leh iyo budo cad-cad

Daahirsanaanta: ≥98.0% (HPLC)

Dhexdhexaadiyaha Favipiravir (CAS: 259793-96-9) ee daaweynta caabuqyada fayraska Hargabka iyo COVID-19

Tayada Sare, Wax Soo Saarka Ganacsiga

Inquiry: alvin@ruifuchem.com


Faahfaahinta Alaabta

Alaabooyinka La Xiriira

Tags Product

Sharaxaad:

Guryaha Kiimikada:

Magaca Kiimikada 6-Fluoro-3-Hydroxypyrazine-2-Carbonitrile
La mid ah 6-Fluoro-3-oxo-3,4-Dihydropyrazine-2-Carbonitrile
Lambarka CAS 356783-31-8
Lambarka CAT RF-API294
Heerka Saamiyada Kaydka, Miisaanka Wax-soo-saarka Ilaa boqollaal Kiilogaram
Qaanuunka molecular C5H2FN3O
Miisaanka Molecular 139.09
Summada Kiimikada Ruifu

Tilmaamaha:

Shayga Tilmaamaha
Muuqashada Jaalle cirro leh iyo budo caddaan ah
Aqoonsiga IR, HPLC
Qoyaanka (KF) ≤1.0%
Hadhaaga dabka ≤0.50%
Xumaanta Keliya ≤1.0%
Wadarta wasakhda ≤2.0%
Biraha culus ≤20pm
daahirnimo ≥98.0% (waxaa qoray HPLC)
Heerka Imtixaanka Heerka Ganacsiga
Isticmaalka Dhexdhexaadiyaha Favipiravir (CAS 259793-96-9);Ka-hortagga fayraska;COVID 19

Xidhmada & Kaydinta:

Xidhmada: Dhalo, boorsada aluminium aluminium, durbaanka kartoonada, 25kg/Drum, ama sida waafaqsan shuruudaha macmiilka.

Xaaladda Kaydinta:Ku kaydi weelasha xiran meel qabow oo qallalan;Ka ilaali iftiinka, qoyaanka iyo cayayaanka.

Faa'iidooyinka

1

FAQ:

Codsiga:

6-Fluoro-3-Hydroxypyrazine-2-Carbonitrile (CAS 356783-31-8) waa dhexdhexaadiye Favipiravir (CAS 259793-96-9).Favipiravir waa daawo cusub oo ka hortag fayrus ah oo ballaaran oo lagu beegsanayo RNA polymerase (RdRp) ku tiirsan RNA.Favipiravir waxaa asal ahaan soo saartay dabayaaqadii 1990-meeyadii shirkad ay markii dambe iibsatay shirkadda Japan ee Fujifilm taasoo qayb ka ahayd ka gudubka ganacsiga sawirka una gudubtay daryeelka caafimaadka.Ka dib markii lagu tijaabiyey noocyo kala duwan oo fayras ah, dawada waxaa laga ansixiyay Japan 2014 si loogu isticmaalo degdegga ah ee ka hortagga hargabka ama lagu daweeyo noocyada cusub ee hargabka.Intii lagu gudajiray faafitaanka coronavirus-ka cusub, natiijooyinka daraasadda bukaan-socodka ee Wajiga I ee daawada la daabacay Maarso 2020 waxay muujisay in daawadu ay yeelan karto saameynta dedejinta nadiifinta fayraska si loo yareeyo horumarka cudurka sambabada cusub ee coronavirus.Favipiravir waxa loo isticmaali karaa daawaynta bukaanada qaba COVID-19 ay WHO ku talisay.Waxaa caddeeyey Maamulaha Guud ee Dawooyinka ee Hindiya (DCGI) isticmaalka "xakamaynta degdega ah" ee bukaannada COVID-19.

Halkan ku qor fariintaada oo noo soo dir